The biosecurity landscape is rapidly evolving. To stay ahead of future outbreaks, we’re partnering with @IsomorphicLabs to outline our approach to bioresilience. Here’s how we’re deploying frontier AI to build proactive defenses for global health →

Learn how Isomorphic Labs' Drug Design Engine uses AI to help solve disease with Anton Osokin from @IsomorphicLabs! Stop by the Google booth (#411#) at 10AM to learn more. #ICLR2026# #IsomorphicLabs# @GoogleDeepMind

I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.

Learn more about how Isomorphic Labs' Drug Design Engine is using artificial intelligence to help solve disease. Join Agnieszka Podsiadlo and Andreas Loukas today at 3:00pm at the Google booth (#B206#) to discuss AI healthcare pipelines. #ICML2026#

Google DeepMind is seeing major leadership changes, per Axios. Demis Hassabis is stepping aside as CEO of @GoogleDeepMind to become chairman of the unit and chief scientist of Alphabet. He will keep leading Isomorphic Labs and focus more on long-term AGI strategy. Koray Kavukcuoglu, the current CTO, will take day-to-day leadership as senior VP, reporting to Sundar Pichai. Jeff Dean, Google’s chief scientist and a 27-year veteran, is leaving with Sanjay Ghemawat, Oriol Vinyals, and Quoc Le to start Discovery Loop, an independent public benefit corporation focused on accelerating ML, science, and engineering discoveries. Google will invest and serve as a cloud partner. The shifts aim to balance near-term AI progress with bigger-picture AGI and scientific work.